Pharmaceutical Membrane Filtration Market worth 6.20 Billion USD by 2021

Emerging membrane filtration technologies along with extensively growing R&D activities are projected to escalate the growth of the membrane filtration market during the forecast period.

(EMAILWIRE.COM, July 10, 2018 ) The report "Pharmaceutical Membrane Filtration Market by Product (MCE, Coated Cellulose Acetate, Nylon, PVDF Membrane), Technique (Microfiltration, Ultra Filtration, Nanofiltration), Application (Final Product, Raw Material) - Global Forecast to 2021", This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global pharmaceutical membrane filtration market along with the estimates and forecasts of the revenue and market share analysis.

Browse 65 market data tables and 35 figures spread through 139 pages and in-depth TOC on “Pharmaceutical Membrane Filtration Market - Global Forecast to 2021"

Download PDF brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=68840418

The global pharmaceutical membrane filtration market is expected to reach USD 6.20 Billion by 2021 from USD 3.55 Billion in 2016, at a CAGR of 11.8% from 2016 to 2021. Factors such as growth in the biopharmaceutical industry and rapid growth in generic drug production are driving the growth of this market.

In this report, the global pharmaceutical membrane filtration market has been segmented based on product, technique, application, and region. On the basis of product, the market has been segmented into MCE membrane filters, coated cellulose acetate membrane filters, nylon membrane filters, PTFE membrane filters, PVDF membrane filters, and other membrane filters. The MCE membrane filters segment is expected to account for the largest share of the market in 2016. The high growth in this segment is primarily attributed to the high adoption rate of membrane filtration products.

Based on technique, the pharmaceutical membrane filtration market has been segmented into microfiltration, ultrafiltration, crossfiltration, nanofiltration, reverse osmosis, and ion exchange. The microfiltration segment is projected to witness the highest CAGR during the forecast period. This growth can be attributed to the high production of pharmaceutical products and drugs.

Based on application, the global pharmaceutical membrane filtration market is segmented into final product processing, raw material filtration, cell separation, water purification, and air purification. The final product processing segment is further divided into active pharmaceutical ingredient (API) filtration, sterile filtration, protein purification, vaccines & antibody processing, formulation & filling solutions, and viral clearance. The final product processing segment is projected to witness the highest growth rate during the forecast period.

Based on region, the global pharmaceutical membrane filtration market is segmented into North America, Asia, Europe, and the Rest of the World (RoW). North America is expected to account for the largest share of the market in 2016. Growth in this regional segment is driven by factors such as increase in generic drug production and increasing incidence of airborne diseases.

Key players in the pharmaceutical membrane filtration market include Merck KGaA (Germany), General Healthcare Company (U.K.), Pall Corporation (U.S.), Sartorius Stedim Biotech Group (France), Alfa Laval (Sweden), Graver Technologies, LLC (U.S.), Koch Membrane Systems Inc. (U.S.), GEA Group (Germany), and Novasep (U.S.).

Make an Inquiry@ https://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=68840418

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com